Position in BIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$56,080,675
-$20,475,699 QoQ
Shares Held
190,997
-30.5% QoQ
Ownership
0.714%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 397 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $10,927,385,431 across 125 Medical Devices names. BIO ranks #22 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
26,611,315 | $2,414,710,711 | |
| 2 | SYK |
Stryker Corp
|
5,960,732 | $1,876,676,853 | |
| 3 | MDT |
Medtronic plc
|
19,444,871 | $1,521,172,249 | |
| 4 | STE |
STERIS plc
|
3,950,067 | $831,765,599 | |
| 5 | BSX |
Boston Scientific Corp
|
18,947,147 | $808,664,224 | |
| 6 | EW |
Edwards Lifesciences Corp
|
6,339,368 | $573,459,221 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
6,223,322 | $398,354,834 | |
| 8 | DXCM |
Dexcom Inc
|
5,156,282 | $347,275,584 |
All Filings in BIO
Export CSV
48 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 BIO-B | $211,100 | 712 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $55,869,575 | 190,285 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 BIO-B | $198,114 | 712 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $76,358,260 | 273,931 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 BIO-B | — | 712 | Shares | Defined | 2025-08-15 | |
| 2025-06-30 | $41,049,251 | 170,103 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 BIO-B | $172,296 | 712 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $47,889,735 | 196,624 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 BIO-B | $231,827 | 712 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $81,564,427 | 248,286 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 BIO-B | — | 712 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $62,550,395 | 186,952 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 BIO-B | — | 712 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $59,269,234 | 217,016 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 BIO-B | — | 724 | Shares | Defined | 2024-08-16 | |
| 2024-03-31 | $87,276,830 | 252,340 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 BIO-B | — | 724 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 | $80,745,417 | 250,071 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 BIO-B | $257,062 | 724 | Shares | Defined | 2023-11-15 | |
| 2023-09-30 | $76,668,147 | 213,888 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 BIO-B | — | 724 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $75,626,852 | 199,480 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 BIO-B | — | 724 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $93,033,821 | 194,217 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 BIO-B | — | 724 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $80,364,463 | 191,121 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 BIO-B | — | 724 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $57,410,975 | 137,630 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 BIO-B | — | 724 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $70,789,455 | 143,009 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 BIO-B | $406,591 | 692 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $37,301,029 | 66,227 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 BIO-B | — | 692 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $86,984,238 | 115,124 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 BIO-B | $525,857 | 692 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $52,905,007 | 70,923 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 BIO-B | $442,880 | 692 | Shares | Defined | 2021-08-23 | |
| 2021-06-30 | $41,667,518 | 64,672 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 BIO-B | — | 692 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $16,314,326 | 28,563 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 BIO-B | $397,311 | 692 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $26,141,358 | 44,844 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 BIO-B | — | 692 | Shares | Defined | 2020-11-13 | |
| 2020-09-30 | $17,988,522 | 34,898 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 BIO-B | $306,752 | 702 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $8,847,848 | 19,597 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 BIO-B | $183,389 | 522 | Shares | Defined | 2020-05-26 | |
| 2020-03-31 | $6,418,049 | 18,308 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||